Application of Renyi entropy for ultrasonic molecular imaging

Department of Medicine, Cardiovascular Division, Washington University School of Medicine, Campus Box 8086, 660 South Euclide Avenue, St. Louis, Missouri 63110-1093, USA.
The Journal of the Acoustical Society of America (Impact Factor: 1.56). 06/2009; 125(5):3141-5. DOI: 10.1121/1.3097489
Source: PubMed

ABSTRACT Previous work has demonstrated that a signal receiver based on a limiting form of the Shannon entropy is, in certain settings, more sensitive to subtle changes in scattering architecture than conventional energy-based signal receivers [M. S. Hughes et al., J. Acoust. Soc. Am. 121, 3542-3557 (2007)]. In this paper new results are presented demonstrating further improvements in sensitivity using a signal receiver based on the Renyi entropy. (C) 2009 Acoustical Society of America. [DOI: 10.1121/1.3097489]


Available from: Jeffrey M Arbeit, Apr 08, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: In several investigations of molecular imaging of angiogenic neovasculature using a targeted contrast agent, Renyi entropy (If(r)) and a limiting form of Renyi entropy (If,∞) exhibited significantly more sensitivity to subtle changes in scattering architecture than energy-based methods. Many of these studies required the fitting of a cubic spline to backscattered waveforms prior to calculation of entropy (either If(r) or If,∞)In this study it is shown that the robustness of If,∞ may be improved by using a smoothing spline. Results are presented showing the impact of different smoothing parameters. In addition, if smoothing is preceded by lowpass filtering of the waveforms, further improvements may be obtained.
    01/2010; DOI:10.1109/ULTSYM.2010.5935961
  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper studies the relationship between the return time tau(n) and the Renyi Entropy Function of order s, R (s). For a dynamical system with an invariant alpha-mixing measure mu and a measurable partition, we consider the sum W of measures of cylinders along orbit segments of length tau(n) and relate that growth/decay rate to the Renyi Entropy. The key strategy is to introduce the hitting number nu(x) (A) = vertical bar{1 <= i <= tau(n)(x) : T-i (x) is an element of A}vertical bar, the number of times that x hits the set A when x travels along its orbit of length tau(n)(x), and write W = Sigma nu(x)(A)mu(A)(s), where the sum is taken over the n-cylinders. Then we show that nu(x)(A) approximate to exp(nh(mu))mu(A) for most n-cylinders A. Hence W approximate to exp(nh(mu)) Sigma(mu)(A)(1+s), which relates tau(n)(x) to R(s), as the sum Sigma mu(A)(1+s) approximate to exp(-nsR(s)).
    Discrete and Continuous Dynamical Systems 06/2013; 33(6). DOI:10.3934/dcds.2013.33.2403 · 0.92 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Herein, we review the use of non-nephrotoxic perfluorocarbon nanoparticles (PFC NPs) for noninvasive detection and therapy of kidney diseases, and we provide a synopsis of other related literature pertinent to their anticipated clinical application. Recent reports indicate that PFC NPs allow for quantitative mapping of kidney perfusion and oxygenation after ischemia-reperfusion injury with the use of a novel multinuclear (1)H/(19)F magnetic resonance imaging approach. Furthermore, when conjugated with targeting ligands, the functionalized PFC NPs offer unique and quantitative capabilities for imaging inflammation in the kidney of atherosclerotic ApoE-null mice. In addition, PFC NPs can facilitate drug delivery for treatment of inflammation, thrombosis, and angiogenesis in selected conditions that are comorbidities for kidney failure. The excellent safety profile of PFC NPs with respect to kidney injury positions these nanomedicine approaches as promising diagnostic and therapeutic candidates for treating and following acute and chronic kidney diseases.
    Advances in chronic kidney disease 11/2013; 20(6):466-78. DOI:10.1053/j.ackd.2013.08.004 · 1.94 Impact Factor